REGISTER
OCC 2026 | The Evolution of HCM Therapy | Prof. Martin Maron
Prof. Martin Maron reviews major milestones in HCM care, from myectomy, alcohol septal ablation, and ICD therapy to genetic discoveries and cardiac myosin inhibitors. The discussion also covers genotype differences, environmental factors, exercise guidance, and remaining questions in HCM management.

In OCC 2026 Quest for Truth roundtable, leading experts from China and the United States gather to discuss “Cardiomyopathy: From Misdiagnosis to Precision Medicine”. The session is hosted by Prof. Gang Wu, MD, PhD, Department of Cardiology, Shanghai General Hospital, and co-hosted by Prof. Zeping Qiu, MD, PhD, Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. Quest for Truth is honored to welcome two distinguished guest speakers: Prof. Martin Maron, MD, PhD, Hypertrophic Cardiomyopathy Center and Research Institute, Tufts Medical Center; and Prof. Wei Jin, MD, PhD, Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine.

The roundtable focuses on “Cardiomyopathy: From Misdiagnosis to Precision Medicine”, with in-depth discussions on hypertrophic cardiomyopathy (HCM) diagnosis and management, genetic testing, cardiac myosin inhibitors, real-world clinical experience, patient-centered treatment decisions, HCM Centers of Excellence, specialist training, and future directions in precision cardiovascular care.

In this segment, Prof. Martin Maron reviews the evolution of HCM care over the past several decades. He highlights major milestones in the field, including surgical myectomy, alcohol septal ablation, ICD therapy for sudden cardiac death prevention, genetic discoveries, and the development of cardiac myosin inhibitors (CMIs).

They also discuss the differences between genotype-positive and genotype-negative HCM, the possible role of environmental factors, and practical guidance on exercise and physical activity for patients. This conversation reflects both the major progress achieved in HCM treatment and the important questions that remain for future research and clinical care.

0
0
Loading